UNSPSC 51172013: Febuprol

This classification denotes a cholagogue or choleretic agent with the molecular formula C13H20O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier B5RKR9Y63Y, chemically known as 2-propanol, 1-n-butoxy-3-phenoxy- but generally known as febuprol, which bears US NIH Compound Identifier 71119. European Medicines Agency schedules Febuprol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07520MIG.

UNSPSC 51172013 Febuprol is a Commodity code that sits at the lowest tier of the taxonomy, yet the recent state and local solicitation activity under this code shows no procurement of febuprol itself—a nonsteroidal anti-inflammatory drug. Instead, Collin County Community Supervision and Corrections Department's RFP 2026-327 for offender specimen collection and drug testing services represents a mismatch between the code assignment and the actual work being bought. The county is soliciting comprehensive drug-testing services, including immunoassay screening with LC/MS/MS or GC/MS confirmation, oral fluid and hair testing, electronic result reporting, and staffing of two collection sites in the Dallas-Fort Worth region. This is a criminal-justice and laboratory-services procurement, not a pharmaceutical supply contract. The issuing body is a county criminal-justice department rather than a healthcare system, pharmacy, or medical procurement office.

Collin County's RFP 2026-327, due July 23, 2026, with an anticipated award date of August 10, 2026, is the primary recent opportunity visible under this code. The estimated contract value is $600,000 for a two-year term commencing September 1, 2026, with three optional one-year renewals not to exceed five years total. The county anticipates approximately 25,031 annual tests across five-panel and six-panel screens and ancillary testing, with pricing on a per-test basis. The vendor must maintain lab certification from SAMHSA, Texas DPS, or CAP. Evaluation will weight vendor understanding (30 points), firm qualifications (25 points), client references (15 points), cost (30 points), with optional Phase 2 demonstrations and interviews worth up to 30 additional points. This code shows minimal recent activity aligned with its pharmaceutical taxonomy designation and warrants low pursuit priority unless your firm offers drug-testing laboratory and specimen-collection services to county criminal-justice systems.